Last Posted: May 24, 2022
- Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies.
Russo A et al. ESMO open 2022 7(3) 100459
- Germline pathogenic variants in unselected Korean men with prostate cancer.
So Min-Kyung et al. Investigative and clinical urology 2022 63(3) 294-300
- Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer.
Kazama Hirotaka et al. BMC cancer 2022 22(1) 470
- Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool.
Anderson Ashley B et al. BMC cancer 2022 22(1) 476
- Development of a clinical polygenic risk score assay and reporting workflow.
Hao Limin et al. Nature medicine 2022
- Artificial intelligence supporting cancer patients across Europe-The ASCAPE project.
Tzelves Lazaros et al. PloS one 2022 17(4) e0265127
- Current Value of Biparametric Prostate MRI with Machine-Learning or Deep-Learning in the Detection, Grading, and Characterization of Prostate Cancer: A Systematic Review.
Michaely Henrik J et al. Diagnostics (Basel, Switzerland) 2022 12(4)
- Association of Family History of Cancer with Clinical and Pathological Outcomes for Prostate Cancer Patients on Active Surveillance.
Jibara Ghalib A et al. The Journal of urology 2022 101097JU0000000000002668
- Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer.
Zhang Wensheng et al. Cancer informatics 2022 2111769351221087046
- Prostate cancer polygenic risk score and prediction of lethal prostate cancer.
Klein Robert J et al. NPJ precision oncology 2022 6(1) 25
Search Result Summary
- CDC Information (5)
- NIH Information (9)
- CDC Publications (1)
- COVID-19 (34)
- Human Genome Epidemiologic Studies (2585)
- GWAS Studies (77)
- Human Genomics Translation/Implementation Studies (459)
- Genomic Tests Evidence Synthesis (46)
- Genomic Tests Guidelines (21)
- Tier-Classified Guidelines (2)
- Non-Genomics Precision Health (120)
- Pathogen Advanced Molecular Detection (2)
- State Public Health Genomics Programs (5)
- Ethical/Legal and Social Issues (ELSI) (6)
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.